Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction

Reut Hod-Dvorai*, Ryan Lee, Penn Muluhngwi, Mariella Raijmakers, Aneesha Shetty, Anat R. Tambur, Michael G. Ison

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: Reduction of immunosuppression (IS) upon detection of Polyomavirus (BK) viremia is widely used to prevent BK virus nephropathy. This retrospective case-control study assesses the frequency of de novo donor-specific antibodies (dnDSA) in renal transplant recipients with IS modulation due to BK viremia and the associated risk of antibody mediated rejection. Methods: Our cohort included recipients of kidney transplantation between 2007 and 2017 with clinical, HLA antibody, and biopsy data. BK positivity was defined as viremia >10 000 c/ml or biopsy proven BK nephropathy. A total of 190 BK cases matched our inclusion criteria, each case was matched with two controls based on gender, donor type, and transplant within 1 year (N = 396). Results: Despite lower number of HLA antigen mismatches (mean = 3.5 vs. 4.4, p <.001), dnDSA rates were higher in BK cases than in control group (22.1% vs. 13.9%, p =.02), with the majority detected following IS reduction for BK infection, and arising earlier posttransplant compared with no BK infection (294d vs. 434d, p <.001). Antibody mediated rejection rates were similar between cases and controls (8.9% and 8.3%, respectively), but rejection was more likely to occur earlier posttransplant in the BK cases (354d vs. 602d, p =.03). Conclusion: Our data suggest a link between IS reduction and the generation of dnDSA and/or rejection, supporting close monitoring for DSA in patients with reduced IS due to BK infection given their increased risk to develop dnDSA. (Figure presented.).

Original languageEnglish (US)
Article numbere13993
JournalTransplant Infectious Disease
Volume25
Issue number1
DOIs
StatePublished - Feb 2023

Keywords

  • BK virus
  • de novo DSA
  • immunosuppression modulation
  • renal transplantation

ASJC Scopus subject areas

  • Transplantation
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Development of de novo donor-specific antibodies in renal transplant recipients with BK viremia managed with immunosuppression reduction'. Together they form a unique fingerprint.

Cite this